2C-T-21

From PsychonautWiki
Jump to: navigation, search
Summary sheet: 2C-T-21
2C-T-21
2C-T-21.svg
Chemical Nomenclature
Common names 2C-T-21, Aurora
Substitutive name 4-Fluoroethylthio-2,5-dimethoxyphenethylamine
Systematic name 4-(2-Fluoroethylthio)-2,5-dimethoxyphenethylamine
Class Membership
Psychoactive class Psychedelic
Chemical class Phenethylamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.



Oral
Dosage
Threshold Common Heavy
5 - 5 - 10 - 12 - 15 mg
Light Strong
Threshold 5 mg
Light 5 - 10 mg
Common 10 - 12 mg
Strong 12 - 15 mg
Heavy 15+ mg
Duration
Total 10 - 12 hours
Onset 90 - 120 minutes
Peak 3 - 4 hours
Offset 2 - 3 hours
After effects 2 - 4 hours









DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

2,5-Dimethoxy-4-ethylfluorothiophenethylamine (also known as 2C-T-21, or colloquially as Aurora) is a psychedelic substance of the phenethylamine chemical class that produces psychedelic effects when administered. It is a member of the 2C-x family of psychedelic phenethylamines, all of which were derived from the systematic modification of the mescaline molecule.

2C-T-21 was first synthesized by Alexander Shulgin and documented in his book PiHKAL ("Phenethylamines I Have Known and Loved"). The dosage range is listed as 8–12 mg. It is described in various reports as being generally relaxed and clear-headed with mild visual effects.[1] In his book "Thanatos To Eros, 35 Years of Psychedelic Exploration", Myron Stolaroff describes it as "not psychedelic, but a wonderful energizer", along with displaying a notable lack of appetite suppression typically observed with members of its class.[2]

In March 2004, a 22-year-old American male died after ingesting an unknown amount of 2C-T-21. This death became part of a two-year DEA investigation called "Operation Web Tryp" which ended with the arrests of 10 persons involved in the online distribution of research chemicals.[3] 2C-T-21 remains unscheduled in the United States.

Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-T-21, and it has little history of human usage. Today, it is used for the purposes of recreation and experimental psychotherapy. It has no history of being sold on the streets and is very sporadically sold online as a grey area research chemical. It is strongly advised to use harm reduction practices if using this substance.

Chemistry

2C-T-21, or 2,5-dimethoxy-4-ethylfluorothiophenethylamine, is a substituted phenethylamine featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain. 2C-T-21 contain methoxy functional groups CH3O- attached to carbons R2 and R5 of the benzene ring as well as an ethylfluoro thioether group attached to carbon R4 of the phenyl ring.

2C-T-21 belongs to the 2C family of phenethylamines, all of which contain methoxy groups on the 2 and 5 positions of the benzene ring.

Pharmacology

Pill bottle-o.png

This pharmacology section is incomplete.

You can help by adding to it.

2C-T-21's psychedelic effects are believed to come from its efficacy at the 5-HT2A receptor as a partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

This compound, being similar in structure to 2C-T-2 and 2C-T-7 is also believed to potentially have MAOI properties.

Subjective effects

Metacogghjgjvghnition.png
This subjective effects section is a stub.

As such, it is still in progress and may contain incomplete or wrong information.

You can help by expanding it.

The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects should be taken with a grain of salt and will rarely (if ever) occur all at once, but heavier doses will increase the chances and are more likely to induce a full range of effects. Likewise, adverse effects become much more likely on higher doses and may include serious injury or death.

Physical effects
Child.svg

Visual effects
Eye.svg

Cognitive effects
User.svg

Auditory effects
Volume-up.svg

Experience reports

There are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:

Toxicity and harm potential

Ambulance2.png

This toxicity and harm potential section is a stub.

As such, it may contain incomplete or even dangerously wrong information. You can help by expanding or correcting it.
We also recommend that you conduct independent research and use harm reduction practices when using this substance.

On March 9, 2004, a 22-year-old American male consumed an unknown dose of 2C-T-21 by sticking his tongue into a vial of powder he had purchased online. He developed a temperature of 108 degrees Fahrenheit (42 degrees Celsius),[4] had a tonic-clonic seizure, and slipped into a coma before dying four days later.[citation needed] Little is known about the toxicity of 2C-T-21 beyond this incident.

It is strongly discouraged to administer 2C-T-21 non-orally because this may cause vomiting, numerous negative side effects, or death at high doses.

It is strongly recommended that one use harm reduction practices, such as volumetric dosing, when using this substance to ensure the accurate administration of the intended dose.

Tolerance and addiction potential

2C-T-21 is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.

Tolerance to the effects of 2C-T-21 are built almost immediately after ingestion. After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption). 2C-T-7 presents cross-tolerance with all psychedelics, meaning that after the consumption of 2C-T-7 all psychedelics will have a reduced effect.

Dangerous interactions

Although many psychoactive substances are safe to use on their own, they can become dangerous or even life-threatening when taken with other substances. The list below contains some potentially dangerous combinations, but may not include all of them. Certain combinations may be safe in low doses but still increase the possibility of injury of death. Independent research should always be conducted to ensure that a combination of two or more substances is safe before consumption.

If 2C-T-21 does have MAOI effects as commonly speculated, this could indicate that 2C-T-21 is more likely to induce serotonin syndrome or general neurotransmitter overload (especially at high dosages) than other serotonergic psychedelics.[5] This may make it dangerous to combine it with other MAOIs, stimulants and certain substances which releases neurotransmitters such as serotonin or dopamine. These substances include but are not limited to:

Legal status

Handcuffs-300px.png

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

  • Canada - As of October 31st, 2016; 2C-T-21 is a controlled substance (Schedule III) in Canada. [6]
  • United Kingdom - 2C-T-21 is a Class A drug in the United Kingdom as a result of the phenethylamine catch-all clause.[7]
  • United States - 2C-T-21 is technically not scheduled in the United States, but could be considered an analogue of 2C-T or 2C-T-7 and may therefore be considered a Schedule I drug under the Federal Analogue Act.

See also

External links

References

  1. https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=49
  2. http://www.maps.org/index.php?option=com_content&view=article&id=5406 | Thanatos to Eros
  3. https://www.dea.gov/pubs/pressrel/pr072204.html
  4. "News from DEA, News Releases, 07/22/04". 
  5. Sulfur-Substituted α-Alkyl Phenethylamines as Selective and Reversible MAO-A Inhibitors:  Biological Activities, CoMFA Analysis, and Active Site Modeling | http://pubs.acs.org/doi/abs/10.1021/jm0493109
  6. http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php
  7. United Kingdom. (1977). Misuse of Drugs Act 1971 (S.I. 1977/1243). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/1977/1243/made